MIR29Bmediates epigenetic mechanisms ofHBGgene activation-Reference-Cited by-同舟云学术

MIR29Bmediates epigenetic mechanisms ofHBGgene activation

Published:2019-03-19 Issue:1 Volume:186 Page:91-100
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Starlard‐Davenport Athena¹^ORCID,Smith Alana¹,Vu Luan²,Li Biaoru³,Pace Betty S.³

Affiliation:

1. Department of Genetics, Genomics and Informatics University of Tennessee Health Science Center Memphis TNUSA

2. Department of Comparative Biomedical Science School of Veterinary Medicine Louisiana State University Baton Rouge LAUSA

3. Department of Pediatrics Division of Hematology/Oncology Augusta University Augusta GA USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15870

Reference42 articles.

1. Decitabine increases fetal hemoglobin in Papio anubis by increasing γ-globin gene transcription

2. Expression of miR‐210 during erythroid differentiation and induction of gamma‐globin gene expression;Bianchi N.;Biochemistry and Molecular Biology Reports,2009

3. Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia

4. LIN28A Expression Reduces Sickling of Cultured Human Erythrocytes

5. Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting DNA methyltransferases for cancer therapy;Bioorganic Chemistry;2024-10

2. Reviewing the impact of hydroxyurea on DNA methylation and its potential clinical implications in sickle cell disease;European Journal of Haematology;2024-06-03

3. Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications;International Journal of Molecular Sciences;2024-04-12

4. Peripheral blood circular RNA circ-0008102 may serve as a novel clinical biomarker in beta-thalassemia patients;European Journal of Pediatrics;2024-01-02

5. RNA therapeutics for the treatment of blood disorders;Progress in Molecular Biology and Translational Science;2024